宜坤行健医药科技(北京)有限公司成立于2022年5月,是一家聚焦肿瘤及炎症领域的创新药物研发公司。公司创始团队具有深厚的产业界经验及投融资背景,公司愿景是通过对疾病发生及药物作用机制的深刻理解及合理的药物分子设计来解决目前无法解决的临床问题。公司在研项目包括免疫调节类的小分子化学药和多肽类药物,同时在搭建高效靶向并穿透实体肿瘤的药物递送平台。公司目前处于早期发展阶段,欢迎有志于创新药研发的优秀人才加入,共创未来!
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows